Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
16.85
+0.83 (5.18%)
At close: Jun 26, 2026, 4:00 PM EDT
16.86
+0.01 (0.04%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Sarepta Therapeutics Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Sarepta Therapeutics stock have an average target of 22.04, with a low estimate of 5.00 and a high estimate of 38. The average target predicts an increase of 30.80% from the current stock price of 16.85.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sarepta Therapeutics stock from 24 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 14 | 13 | 13 | 12 | 13 | 13 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 26 | 25 | 25 | 25 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $20 | Hold | Maintains | $20 | +18.69% | Jun 22, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $19 | Hold | Maintains | $19 | +12.76% | Jun 18, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | +12.76% | May 19, 2026 |
| Evercore ISI | Evercore ISI | Hold Maintains $20 → $19 | Hold | Maintains | $20 → $19 | +12.76% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $35 | Buy | Maintains | $35 | +107.72% | May 15, 2026 |
Financial Forecast
Revenue This Year
1.84B
from 2.20B
Decreased by -16.39%
Revenue Next Year
1.42B
from 1.84B
Decreased by -22.53%
EPS This Year
4.83
from -5.05
EPS Next Year
2.73
from 4.83
Decreased by -43.57%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.1B | 1.9B | |
| Avg | 1.8B | 1.4B | |
| Low | 1.7B | 880.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -6.5% | 1.8% | |
| Avg | -16.4% | -22.5% | |
| Low | -22.8% | -52.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.30 | 5.22 | |
| Avg | 4.83 | 2.73 | |
| Low | 3.45 | 0.98 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 8.1% | |
| Avg | - | -43.6% | |
| Low | - | -79.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.